Johnson & Johnson stock falls Tuesday, underperforms market

This post was originally published on this site

© Terrence Horan

COMPANY CLOSE UPDATES

Video: Banks will deliver strong earnings due to ‘credit euphoria,’ top analyst Mike Mayo predicts (CNBC)

Banks will deliver strong earnings due to ‘credit euphoria,’ top analyst Mike Mayo predicts
What to watch next

Shares of Johnson & Johnson slid 1.60% to $157.69 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.24% to 4,350.65 and Dow Jones Industrial Average falling 0.34% to 34,378.34. This was the stock’s third consecutive day of losses. Johnson & Johnson closed $22.23 below its 52-week high ($179.92), which the company reached on August 20th.

The stock underperformed when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. fell 0.89% to $381.51, Merck & Co. Inc. fell 0.43% to $79.59, and Pfizer Inc. fell 0.50% to $41.85. Trading volume (6.7 M) eclipsed its 50-day average volume of 5.7 M.

Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading